ප්රෝටීන් සංස්ලේෂණය කිරීම සඳහා භාවිතා කරන ඇමයිනෝ අම්ලයේ අපිරිසිදුකම

NO

නිෂ්පාදන

Ca මන්ත්රී

ප්රධාන ගුණාත්මක දර්ශකය

සංශුද්ධතාවය

උපරිම.

අපිරිසිදුකම

මුළු ද්රාවෙනි අපද්රව්ය

තෙතමනය

1

FMOC-β-Ala-Ala-ALO

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

FMOC-D-D-AL-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

FMOC-β- ඇල-ඩී-අලා-ඔහ්

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMOC-ARG (PBF) -ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-al-arg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

FMOC-D-ARG (PBF) -D-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-al-ala-d-arg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-HOMOABRG (PBF) - හෝමොමර්ග් (පීබීඑෆ්) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-al-Ala-hommab (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

FMOC-asn (trt) --ass (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-al-asn (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

FMOC-ASP (OTBU) - ඇස්ප් (ඔට්බු) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-al-Al-ASP (OTBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

FMOC-CYS (TRT)-සීඕසී (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-al-ala-cys (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

FMOC-CYS (ACM) -CYS (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-al-Ala-cys (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

FMOC-gln (trt) --gln (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-al-al-gln (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

FMOC-glu (OTBU) - ජීඑල්ඕ (ඔට්බු) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-al-alllu (Otbu) -oh.h2o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

FMOC-β-Ala-gly-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

FMOC - ඔහුගේ (TRT) -HIS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-ala-ha-he (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

FMOC-ile-ile-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-Ala-ile-ile-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

FMOC-LEU-LEU-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

FMOC-β-ala-leu-ro

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

FMOC-D-D-LEU-D-D-LEU-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

FMOC-β-al-Ala-d-leu-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

FMOC-LYS (BOC) --lys (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-Ala-lis (BoC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

FMOC-LYS (DESS (DES) --OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

FMOC-β-Ala-lis (All And) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

FMOC-Ment-ment-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

FMOC-β-a-ala-ment-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

FMOC-ORN (BOC) --o (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-al-orn-orn (Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

FMOC-PHE-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

FMOC-β-ala-phe-phe

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

FMOC-D-D-PHE-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

FMOC-β-Ala-d-phe-Ou

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

FMOC-Pro-Pro-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

FMOC-β-ala-pro-pro-o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

FMOC-SER (TBU) --සර් (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-al-ala-ser (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

FMOC-SER (TRT) --සර් (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β-al-ala-ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

FMOC-thr (Tbu) --thr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-al-al-thr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

FMOC-TRP (BOC) -TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

FMOC-β-al-Al-trp (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-al-Ala-d-trp (BOC) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

FMOC-TYR (TBU) -tyr (Tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-al-tal-tyr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

FMOC-D-TYR (ET) -D-TYR (ET) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-al-Ala-d-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

FMOC-TYR (ME) -TIR (ME) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

FMOC-β-al-al-tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

FMOC-Val-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

FMOC-β-ala-val-val-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D-CIT-D-D CIT-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-β-al-Ala-d-cit-cit-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

FMOC-β-al-ala-dab-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

FMOC- (3- (2-naphyl) -d-ala) 2-අනේ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-al-alat-3- (2-naphyl) -d-Ala-O.

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

FMOC- (3- (3-pyridyinyl) -d-ala) 2-අනේ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-β-alat-3- (3-pyridyinyl) -d-ala-o

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4-ක්ලෝරෝ-ඩී-පීඊ) 2-අනේ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-β-al-ala-4-chloro-d-phe-op

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4APH (TBUCBM)) 2-අනේ

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-al-ala-d-4aph (tbucbm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

FMOC-APH (L-HA) -ah (L-HO) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-al-alah (l-ha) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

FMOC-LYS (IPR, BOC) --lys (ipr, Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-al-al-lis (ipr, Boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

FMOC-β-Ale-AEEA-OHA

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

FMOC-AIB-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

FMOC-β-ala-aib-aib-Oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

FMOC-ARG-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-arg (pbf) -oh

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

FMOC-D-D-ARG-OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-ARG (PBF) -OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

FMOC-HOMOARG-OHICL

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-homabarg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

FMOC-D-HOMABARG-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-HOMOABRG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

FMOC-ASN-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-asn (trt) -oh

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

FMOC-ASP-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

H-ASP (OTBU) -OH

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

FMOC-CYS-OH

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

H-cys (trt) -oh

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-cys (Acm) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

FMOC-gln-Oh

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-gln (trt) -oh

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

FMOC-gllu-Oh

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

එච්-ග්ලෝ (ඔට්බු) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

FMOC - ඔහුගේ-ඔහ්

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

එච්-ඔහුගේ (trt) -oh

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

BOC-ඔහුගේ-OH

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

FMOC-LYS-OH

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

එච්-ලයිස් (BOC) -OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-LIS (Addly) -oh

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

FMOC-ORN-OHI.HCL

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

එච්-ඕර්න් (BOC) -oh

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

FMOC-SER-OH

73724-45-5-5-5-5-5-5-5-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-ser (tbu) -oh

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

FMOC-thr-om2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-whr (tbu) -oh

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

FMOC-TRP-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-TRP (BOC) -oh

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

FMOC-D-DRP-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -oh

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

FMOC-TYR-OH

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-tyr (tbu) -oh

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

FMOC-D-TYR-OH

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-TYR (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

H-tyr (me) -oh.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4APH (CBM) -OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

HD-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

FMOC-LYS (IPR) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

එච්-ලයිස් (අයි.පී.ආර්., BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%